Corporate Presentation Corporate Presentation ASN 2022 Presentations Atacicept Reduces Serum Immune Complex Levels in IgAN Patients A Randomized Phase 2 Study of MAU868 vs Placebo to Treat BK Viremia in Kidney Transplant Recipients – Week 36 Results ERA EDTA 2022 Presentations 2022 ERA EDTA anti GdlgA1 2022 ERA EDTA April SLE Renal ASN 2021 E-Poster Presentation Atacicept Reduces Serum Gd-IgA1 by Quartiles in IgAN Patients Investor Calendar and Recordings ASN 2022 Presentations Atacicept Reduces Serum Immune Complex Levels in IgAN Patients A Randomized Phase 2 Study of MAU868 vs Placebo to Treat BK Viremia in Kidney Transplant Recipients – Week 36 Results
A Randomized Phase 2 Study of MAU868 vs Placebo to Treat BK Viremia in Kidney Transplant Recipients – Week 36 Results
A Randomized Phase 2 Study of MAU868 vs Placebo to Treat BK Viremia in Kidney Transplant Recipients – Week 36 Results
